Literature DB >> 2411842

The cell surface molecule recognized by the erythrocyte receptor of T lymphocytes. Identification and partial characterization using a monoclonal antibody.

T Hünig.   

Abstract

A monoclonal antibody (mAb) to sheep red blood cells (SRBC), termed L180/1, is described that completely blocks rosette formation between SRBC and human or sheep T lymphocytes. L180/1 precipitated a minor glycoprotein of about approximately 42,000 mol wt from surface-labeled SRBC. This glycoprotein was partially affinity purified and found to block E rosette formation and to compete with anti-T11 mAb for the E receptor. The molecule detected by mAb L180/1 thus appears to be recognized by the E receptor and was given the preliminary name, T11 target structure (T11TS). Since the mAb to sheep T11TS blocks the binding of SRBC to both human and sheep T cells, and mAb to T11 blocks the binding of red cells from human and sheep to the human E receptor, we concluded that analogous receptor-ligand (T11-T11TS) systems exist in man and sheep that are crossreactive over the species barrier. The possibility is discussed that the E receptor, which is known to be involved in T cell activation, and T11TS function as complementary cell interaction molecules in T cell responses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411842      PMCID: PMC2187812          DOI: 10.1084/jem.162.3.890

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Studies on glycopeptide released by trypsin from sheep erythrocytes.

Authors:  T Kitao; M Takeshita; K Hattori
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

2.  Functional consequences of sheep red blood cell rosetting for human T cells: gain of reactivity to mitogenic factors.

Authors:  E L Larsson; J Andersson; A Coutinho
Journal:  Eur J Immunol       Date:  1978-10       Impact factor: 5.532

3.  Inhibition of human lymphocyte rosetting by anti-T sera.

Authors:  H H Worth; A G Cooper; M C Brown
Journal:  Nat New Biol       Date:  1973-05-23

4.  Binding of sheep red blood cells to a large population of human lymphocytes.

Authors:  W H Lay; N F Mendes; C Bianco; V Nussenzweig
Journal:  Nature       Date:  1971-04-23       Impact factor: 49.962

5.  Human T cell antigen expression by primate T cells.

Authors:  B F Haynes; D L Dowell; L L Hensley; I Gore; R S Metzgar
Journal:  Science       Date:  1982-01-15       Impact factor: 47.728

6.  A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation.

Authors:  F D Howard; J A Ledbetter; J Wong; C P Bieber; E B Stinson; L A Herzenberg
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

7.  Rosette formation between human lymphocytes and sheep erythrocytes. Inhibition of rosette formation by specific glycopeptides.

Authors:  D H Boldt; J P Armstrong
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

8.  Glycolipid and p 40 are the binding sites in the sheep erythrocyte and T-lymphocyte membrane responsible for rosette formation.

Authors:  L G Gürtler
Journal:  Immunobiology       Date:  1981-06       Impact factor: 3.144

Review 9.  The organization of proteins in the human red blood cell membrane. A review.

Authors:  T L Steck
Journal:  J Cell Biol       Date:  1974-07       Impact factor: 10.539

10.  Identification of a human T lymphocyte surface protein associated with the E-rosette receptor.

Authors:  M Kamoun; P J Martin; J A Hansen; M A Brown; A W Siadak; R C Nowinski
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  22 in total

1.  Surface expression of differentiation antigens on lymphocytes in the ileal and jejunal Peyer's patches of lambs.

Authors:  W R Hein; L Dudler; C R Mackay
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

2.  Restricted expression of CD2 among subsets of sheep thymocytes and T lymphocytes.

Authors:  G W Giegerich; W R Hein; M Miyasaka; G Tiefenthaler; T Hünig
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

Review 3.  Soluble inhibitors of T lymphocyte proliferation: tools for dissecting pathways of T cell activation.

Authors:  J C Reed; P C Nowell
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

4.  One sequence, two folds: a metastable structure of CD2.

Authors:  A J Murray; S J Lewis; A N Barclay; R L Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

5.  Structural study of N-linked sugar chains of sheep erythrocyte membrane glycoproteins.

Authors:  K Kusui; S Takasaki
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

6.  T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells.

Authors:  Debanjan Bhattacharya; Manoj Kumar Singh; Suhnrita Chaudhuri; Sagar Acharya; Anjan Kumar Basu; Swapna Chaudhuri
Journal:  J Neurooncol       Date:  2013-03-08       Impact factor: 4.130

7.  Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.

Authors:  Rushikesh Sable; Thomas Durek; Veena Taneja; David J Craik; Sandeep Pallerla; Ted Gauthier; Seetharama Jois
Journal:  ACS Chem Biol       Date:  2016-07-01       Impact factor: 5.100

8.  Molecular cloning of the human T-lymphocyte surface CD2 (T11) antigen.

Authors:  W A Sewell; M H Brown; J Dunne; M J Owen; M J Crumpton
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Heterogeneity in the activation requirements of T cells stimulated by phytohaemagglutinin.

Authors:  H S Warren; A Bezos
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

10.  The T11(3) epitope of the CD2 molecule, sheep erythrocytes, and the alternative T-cell activation pathway.

Authors:  H S Warren; V McPhun; A Bezos; C R Parish
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.